GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » Accounts Payable & Accrued Expense

Adicon Holdings (HKSE:09860) Accounts Payable & Accrued Expense : HK$1,301 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings Accounts Payable & Accrued Expense?

Adicon Holdings's quarterly accounts payable & accrued expense declined from Dec. 2023 (HK$1,512 Mil) to Jun. 2024 (HK$1,262 Mil) but then increased from Jun. 2024 (HK$1,262 Mil) to Dec. 2024 (HK$1,301 Mil).

Adicon Holdings's annual accounts payable & accrued expense declined from Dec. 2022 (HK$2,181 Mil) to Dec. 2023 (HK$1,512 Mil) and declined from Dec. 2023 (HK$1,512 Mil) to Dec. 2024 (HK$1,301 Mil).


Adicon Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Adicon Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Accounts Payable & Accrued Expense Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
856.88 1,334.68 2,180.91 1,512.37 1,300.78

Adicon Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial 2,180.91 1,753.75 1,512.37 1,261.52 1,300.78

Adicon Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Adicon Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN
Founded in 2004 and listing on the Hong Kong Exchange in 2023, Adicon is one of the largest independent clinical laboratories in China. In October 2018, private equity Carlyle Group completed its investment in Adicon and has since been the largest single shareholder. Following Carlyle's investment, Adicon quickly stepped up its footprint. It has a testing portfolio of over 4,000 medical diagnostic tests with 34 self-operated laboratories in 2024, compared with 1,800 items and 21 labs in 2018. Currently, esoteric tests account for nearly 60% of its testing portfolio. Esoteric tests require more specialized technologies and/or equipment.
Executives
Cap V General Partner, L.p. 2201 Interest of corporation controlled by you
Cap V, L.l.c. 2201 Interest of corporation controlled by you
Carlyle Asia Partners V, L.p. 2201 Interest of corporation controlled by you
Carlyle Holdings Ii Gp L.l.c. 2201 Interest of corporation controlled by you
Carlyle Holdings Ii L.l.c. 2201 Interest of corporation controlled by you
Cg Subsidiary Holdings L.l.c. 2201 Interest of corporation controlled by you
Pearl Group Limited 2101 Beneficial owner
Tc Group Cayman Investment Holdings L.p. 2201 Interest of corporation controlled by you
Tc Group Cayman Investment Holdings Sub L.p. 2201 Interest of corporation controlled by you
The Carlyle Group Inc. 2201 Interest of corporation controlled by you
Lin Feng
Mega Stream Limited
Trident Trust Company (hk) Limited 2301 Trustee
Ingenuity Capital Holdings Limited 2201 Interest of corporation controlled by you
Corelink Group Limited

Adicon Holdings Headlines

No Headlines